The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO WCGIC 2021 | Impact of gender and HPV status on anal squamous cell carcinoma survival
Firas Baidoun, MD, Cleveland Clinic, Cleveland, OH, talks on the impact of gender and HPV status on overall survival (OS) in patients with anal squamous cell carcinoma using the National Cancer Database. Females had better OS only in non-metastatic anal squamous cell carcinoma, in addition HPV-negative status was associated with worse OS only in patients with metastatic anal squamous cell carcinoma. This interview took place at the ESMO World Congress on Gastrointestinal Cancer 2021.
